Key Stats for Salesforce Stock
- Current Price: $166.11
- Target Price (Mid): ~$320
- Street Target: ~$246
- Potential Total Return: ~92%
- Annualized IRR: ~15% / year
- Max Drawdown: -45.14% (June 22, 2026)
Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free) >>>
What Happened?
Salesforce, Inc. (CRM) got something in July it had not seen much of all year: a bank willing to argue the sell-off has gone too far. On July 1, Guggenheim analyst John DiFucci upgraded the stock to Buy with a $228 target, and he did not hedge the language. He said the AI doom scenario priced into Salesforce stock in 2026 is “misaligned with reality.” Shares jumped about 5% on the day.
That upgrade matters less for the $228 number than for what it signals about where consensus is starting to move. For six months, the debate on Salesforce has been one-sided. The stock has spent 2026 absorbing a single fear, that the AI agents Salesforce now sells will quietly retire the human seats its customers have paid for since 1999. DiFucci is not dismissing that fear. He calls AI a “significant risk.” He is arguing something narrower and more interesting: that the market has priced an extinction event into a company that is still growing double digits and printing cash.
The question this upgrade forces is simple. Is the Street finally seeing the business clearly, or is it catching a falling knife at 3x sales because the chart looks cheap?
Why the Upgrade Is a Valuation Call, Not an AI Cheer
DiFucci’s logic rests on a gap between price and fundamentals. Salesforce trades at roughly 3x sales and about 12x next twelve months earnings, near the cheapest levels in the company’s public history. He also pointed to the aggressive $25 billion accelerated share buyback, a program that retired 103 million shares (about 10% of the count) in the first quarter alone, as evidence that the company is compounding value while the market looks away.
The concrete proof point behind the call is Agentforce, Salesforce’s platform for deploying autonomous AI agents across sales, service, and marketing. It reached $1.2 billion in annual recurring revenue by the end of Q1, up from $800 million the prior quarter. That is real revenue attached to the exact product bears assume will cannibalize the core. The skeptics cannot easily wave it away.
The stock’s reaction to fundamentals tells you how deep the fear runs. Salesforce beat Q1 FY27 badly, non-GAAP EPS of $3.88 topped the $3.13 consensus by roughly 24%, and non-GAAP operating margin hit a record 34.8%. The stock barely moved, closing down 0.75% on the May 27 report. When a 24% earnings beat produces a shrug, the market is not trading on results. It is trading on a thesis about the future.
See historical and forward estimates for Salesforce stock (It’s free!) >>>
The Insight the Upgrade Note Missed
Here is what most bears and even most bullish analysts have not connected. The companies supposedly most likely to disrupt Salesforce, the frontier AI labs, are among its heaviest users.
At the Mizuho Technology Conference on June 9, President and CMO Patrick Stokes was asked directly why the fear that AI labs will decelerate Salesforce is wrong. His answer reframed the whole debate.
“Many of these labs are run by, have people in the go-to-market organization that we know, they’re all using Salesforce extensively, in fact, more than some of our biggest customers.” — Patrick Stokes, President and CMO, Salesforce
Why it matters: The labs are not replacing Salesforce; they are consuming more of it, just through a different door. Stokes explained that they do not log into the user interface the way customers have for 20 years. They reach Salesforce through their own agentic tools, hooking in through MCP (Model Context Protocol, an open standard that lets AI agents from any platform connect without custom integrations). That usage runs through Headless 360, Salesforce’s move to expose its data and CRM layer through open interfaces. Stokes said that as a result, “we’re seeing usage spike up quite a bit.”
That is the crux of the bull case the DiFucci note gestures at but does not fully make. If the agentic era drives consumption up rather than seats down, the cannibalization math the bears run is incomplete. Stokes put the strategic choice bluntly: rival software firms saw the same shift and were “terrified” of losing their interface, while Salesforce “took the exact opposite approach and said, no, we endorse it.”
The Move That Turns Usage Into Revenue
Optimism about consumption only pays if Salesforce can bill for it. Salesforce announced in early June that it would buy m3ter, a metering and rating platform built for usage-based billing, and the deal closed on July 1. It folds into Agentforce Revenue Management and gives Salesforce the machinery to charge for what agents do rather than how many people hold licenses.
That is the plumbing behind the pricing model Stokes described as still unsettled. Management is experimenting with consumption pricing, unlimited-usage agreements, and likely a per-agent license, and Stokes admitted the company has not yet found the “Goldilocks” model. m3ter is the infrastructure bet that lets it keep experimenting without leaving money on the table. As Meredith Schmidt, EVP and GM of Agentforce Revenue Management, framed it, AI is shifting monetization “from traditional subscriptions to consumption-based models.” The market read the deal as plumbing rather than growth and largely ignored it. That is precisely the disconnect DiFucci is trying to arbitrage.
Where the Discount Stops Making Sense
Relative to peers, the pricing looks less like caution and more like a verdict. Salesforce trades at an NTM EV/EBITDA, a forward enterprise-value-to-earnings multiple, of 9.65x. That sits against a software peer group averaging roughly 29x on the same measure, per TIKR’s Competitors data. ServiceNow trades near 16.58x and Microsoft near 12.83x. The largest and most cash-generative name in the comparison is priced below nearly all of them.
A discount that wide only makes sense if you believe Salesforce’s growth permanently stalls. The company generated roughly $14 billion in free cash flow in fiscal 2026, grew revenue 13% in Q1, and is buying back stock at a record pace. The bearish read is that seat erosion eventually hits the top line faster than Agentforce and consumption revenue can fill the gap, and that $1.2 billion in Agentforce ARR is still small against a roughly $46 billion revenue run rate. Both things are true at once, which is why the stock sits where it does. The upgrade is a bet that the fear is running ahead of the erosion.
See how Salesforce performs against its peers in TIKR (It’s free!) >>>
TIKR Advanced Model Analysis
- Current Price: $166.11
- Target Price (Mid): ~$320
- Potential Total Return: ~92%
- Annualized IRR: ~15% / year
See analysts’ growth forecasts and price targets for Salesforce stock (It’s free!) >>>
The model targets around $320 per share, about 92% total return over roughly 4.6 years. Two revenue drivers carry the forecast: continued double-digit subscription growth across the core clouds, and the ramp of Agentforce and consumption revenue as the m3ter billing layer comes online. The margin driver is operating leverage, with net income margin modeled to expand from around 26% today toward about 28% as agents scale without proportional headcount. The primary risk is that consumption revenue grows too slowly to offset seat erosion before it reaches the top line.
The upside: if Agentforce adoption accelerates and the seat headwind proves milder than feared, the high case reaches around $665 at roughly 18% annually.
The downside: if AI reduces seat counts faster than consumption revenue can replace them, the low case still points to around $390, near 11% annually, because the buyback and cash generation cushion the fall.
Conclusion
One upgrade does not end a six-month argument, and DiFucci’s $228 target still sits below the Street mean near $246. The line that settles this is organic revenue growth, and the date is Salesforce’s Q2 FY27 report, expected August 26. Management has guided the second half of FY27 to accelerate.
“Good” looks like organic subscription growth reaccelerating off the roughly 8% constant-currency pace seen last quarter, with Agentforce ARR climbing toward its next billion. “Bad” looks like growth drifting lower while the acquisitions stay invisible in the revenue line. If the reacceleration shows up in August, the bulls’ case ages well, and the 45% drawdown starts to look like a bottom. If it does not, the market will keep pricing Salesforce as a melting seat business no matter how much cash it prints. Watch the top line on August 26.
See what stocks billionaire investors are buying so you can follow the smart money with TIKR.
Should You Invest in Salesforce?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up Salesforce, and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track Salesforce alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Analyze Salesforce on TIKR Free →
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
